Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Jessica Xavier, Alissa Greer, Alexis Crabtree & Jane A. Buxton. (2023) Police officers’ perceptions of their role at overdose events: a qualitative study. Drugs: Education, Prevention and Policy 30:4, pages 361-372.
Read now
Read now
Randa Abdelal, A. Raja Banerjee, Suzanne Carlberg-Racich, Neyla Darwaza, Diane Ito & Josh Epstein. (2022) The need for multiple naloxone administrations for opioid overdose reversals: A review of the literature. Substance Abuse 43:1, pages 774-784.
Read now
Read now
Ola Dale. (2022) Pharmacokinetic considerations for community-based dosing of nasal naloxone in opioid overdose in adults. Expert Opinion on Drug Metabolism & Toxicology 18:3, pages 203-217.
Read now
Read now
Tabitha E. Moses, May Chammaa, Rafael Ramos, Eva Waineo & Mark K. Greenwald. (2021) Incoming medical students’ knowledge of and attitudes toward people with substance use disorders: Implications for curricular training. Substance Abuse 42:4, pages 692-698.
Read now
Read now
Jordan Wrigley, Caitlin Kennedy, Mary Grace Flaherty, Madison Ponder, Meg Foster & Jesse Akman. (2020) A Statewide Analysis of North Carolina Public Libraries and Their Response to the Opioid Epidemic. Public Library Quarterly 39:5, pages 421-433.
Read now
Read now
Shawn A Ryan & Robert B Dunne. (2018) Pharmacokinetic Properties of Intranasal and Injectable Formulations of Naloxone for Community use: a Systematic Review. Pain Management 8:3, pages 231-245.
Read now
Read now
Hayley Wight & Jerry H. Ratcliffe. Aiding or enabling? Officer perspectives on harm reduction and support services in an open-air drug market. Policing and Society 0:0, pages 1-16.
Read now
Read now
Katie A. McCormick, Jake Samora, Kasey R. Claborn, Lori K. Holleran Steiker & Diana M. DiNitto. A systematic review of macro-, meso-, and micro-level harm reduction interventions addressing the U.S. opioid overdose epidemic. Drugs: Education, Prevention and Policy 0:0, pages 1-14.
Read now
Read now
Articles from other publishers (21)
Paige M. Lemen, Daniel P. Garrett, Erin Thompson, Megan Aho, Christina Vasquez & Ju Nyeong Park. (2024) High-dose naloxone formulations are not as essential as we thought. Harm Reduction Journal 21:1.
Crossref
Crossref
Teijo I. Saari, John Strang & Ola Dale. (2024) Clinical Pharmacokinetics and Pharmacodynamics of Naloxone. Clinical Pharmacokinetics 63:4, pages 397-422.
Crossref
Crossref
David Perlmutter, Courteney Wettemann, Callan Elswick Fockele, Tessa Frohe, Will Williams, Nathan Holland, Thea Oliphant-Wells, Hendrika Meischke & Jenna van Draanen. (2023) “Another tool in the toolkit”—Perceptions, suggestions, and concerns of emergency service providers about the implementation of a supervised consumption site. International Journal of Drug Policy 115, pages 104005.
Crossref
Crossref
Yvon Yeo, Rosemary Johnson & Christine Heng. (2022) The Public Health Approach to the Worsening Opioid Crisis in the United States Calls for Harm Reduction Strategies to Mitigate the Harm From Opioid Addiction and Overdose Deaths. Military Medicine 187:9-10, pages 244-247.
Crossref
Crossref
Stevie C. Britch & Sharon L. Walsh. (2022) Treatment of opioid overdose: current approaches and recent advances. Psychopharmacology 239:7, pages 2063-2081.
Crossref
Crossref
Phil Skolnick. (2022) Treatment of overdose in the synthetic opioid era. Pharmacology & Therapeutics 233, pages 108019.
Crossref
Crossref
Rebecca McDonald, Sibella Breidahl, Katri Abel-Ollo, Shabana Akhtar, Thomas Clausen, Ed Day, Mike Kelleher, Andrew McAuley, Helle Petersen, Martin Sefranek, Henrik Thiesen & John Strang. (2022) Take-Home Naloxone Kits: Attitudes and Likelihood-Of-Use Outcomes from a European Survey of Potential Overdose Witnesses. European Addiction Research 28:3, pages 220-225.
Crossref
Crossref
Katie Kanter, Ryan Gallagher, Feyisope Eweje, Alexander Lee, David Gordon, Stephen Landy, Julia Gasior, Haideliza Soto-Calderon, Peter F. Cronholm, Ben Cocchiaro, James Weimer, Alexis Roth, Stephen Lankenau & Jacob Brenner. (2021) Willingness to use a wearable device capable of detecting and reversing overdose among people who use opioids in Philadelphia. Harm Reduction Journal 18:1.
Crossref
Crossref
Gillian A Beauchamp, Hoonani M Cuadrado, Seth Campbell, Bennie B Eliason, Chase L Jones, Aaron T Fedor, Lauren Grantz, Paige Roth & Marna Rayl Greenberg. (2021) A Study on the Efficacy of a Naloxone Training Program. Cureus.
Crossref
Crossref
Victor M. JimenezJr.Jr., Gabriel Castaneda & Charles P. France. (2021) Methocinnamox Reverses and Prevents Fentanyl-Induced Ventilatory Depression in Rats. Journal of Pharmacology and Experimental Therapeutics 377:1, pages 29-38.
Crossref
Crossref
Miriam Boeri & Aukje K. Lamonica. (2021) Naloxone perspectives from people who use opioids: Findings from an ethnographic study in three states. Journal of the American Association of Nurse Practitioners 33:4, pages 294-303.
Crossref
Crossref
Jeanne L. Jacoby, Lauren M. Crowley, Robert D. Cannon, Kira D. Weaver, Tara K. Henry-Morrow, Kathryn A. Henry, Allison N. Kayne, Colleen E. Urban, Robert A. Gyory & John F. McCarthy. (2020) Pennsylvania law enforcement use of Narcan. The American Journal of Emergency Medicine 38:9, pages 1944-1946.
Crossref
Crossref
Stephen Parkin, Joanne Neale, Caral Brown, Aimee N.C. Campbell, Felipe Castillo, Jermaine D. Jones, John Strang & Sandra D. Comer. (2020) Opioid overdose reversals using naloxone in New York City by people who use opioids: Implications for public health and overdose harm reduction approaches from a qualitative study. International Journal of Drug Policy 79, pages 102751.
Crossref
Crossref
Gia Elise Barboza & Kate Angulski. (2020) A descriptive study of racial and ethnic differences of drug overdoses and naloxone administration in Pennsylvania. International Journal of Drug Policy 78, pages 102718.
Crossref
Crossref
Philip Krieter, Shwe Gyaw, Roger Crystal & Phil Skolnick. (2019) Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose. Journal of Pharmacology and Experimental Therapeutics 371:2, pages 409-415.
Crossref
Crossref
John Strang, Rebecca McDonald, Gabrielle Campbell, Louisa Degenhardt, Suzanne Nielsen, Alison Ritter & Ola Dale. (2019) Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine. Drugs 79:13, pages 1395-1418.
Crossref
Crossref
Jarkko Johansson, Jussi Hirvonen, Zsófia Lovró, Laura Ekblad, Valtteri Kaasinen, Olli Rajasilta, Semi Helin, Jouni Tuisku, Saija Sirén, Mirka Pennanen, Arvind Agrawal, Roger Crystal, Petri J. Vainio, Hannu Alho & Mika Scheinin. (2019) Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects. Neuropsychopharmacology 44:9, pages 1667-1673.
Crossref
Crossref
Lisa R. Gerak, David R. Maguire, James H. Woods, Stephen M. Husbands, Alex Disney & Charles P. France. (2019)
Reversal and Prevention of the Respiratory-Depressant Effects of Heroin by the Novel
μ
-Opioid Receptor Antagonist Methocinnamox in Rhesus Monkeys
. Journal of Pharmacology and Experimental Therapeutics 368:2, pages 229-236.
Crossref
Crossref
Lisa R. Gerak, David R. Maguire & Charles P. France. 2020. Substance Use Disorders. Substance Use Disorders
127
145
.
Elisabeth Frauger, Farid Kheloufi, Quentin Boucherie, Emilie Monzon, Leonard Jupin, Nathalie Richard, Michel Mallaret & Joëlle Micallef. (2018) Intérêt de la mise à disposition de la naloxone auprès des usagers de drogues pour le traitement d’urgence de surdosage d’opioïdes. Therapies 73:6, pages 511-520.
Crossref
Crossref
Yahya Fdidine. (2022) Social Stratification of Entrepreneurs in Proliferating Customers. SSRN Electronic Journal.
Crossref
Crossref